Similar Posts
Mauritius tax protocol to give Indian taxman more powers to probe offshore entities
Mumbai: A decision by the Mauritius cabinet would soon give Indian tax officials more powers to directly question the offshore arms of foreign investors if they suspect that such entities were formed with the prime intention to escape tax. The Mauritius cabinet last week ratified a 2024 tax protocol for amending the agreement between India…
Die Feier zum 11. Jubiläum von Anycubic steht bevor: 11 Jahre, 11 Millionen Ideen
SHENZHEN, China, 28. August 2026 /PRNewswire/ — Anycubic, eine weltweit tätige Marke im Bereich 3D-Druck, bereitet sich darauf vor, ihr 11-jähriges Jubiläum unter dem Motto „11 Jahre, 11 Millionen Ideen: Mit Anycubic Ideen verwirklichen” zu feiern. Ab dem 2. September bietet der Jubiläumsverkauf Sonderpreise, die „Anniversary Mystery Box”, eine Creator-Kampagne sowie zusätzliche Mitgliedervorteile für Anycubic-Nutzer weltweit….
JLB Pursuing Buckhead Office-to-Apartments Conversion
JLB Partners plans to redevelop a seven-story building at 470 E. Paces Ferry Road in Buckhead Village. The Atlanta Business Chronicle reports the project consists of 314 apartments in what was once a mid-century office building. On Maple Drive, the 1960s-era office building is the longtime home of Logility Supply Chain Solutions. Aptean acquired Logility…
Five Notable ETF Launches Reshape Investment Landscape
There were 728 new ETFs listed in the U.S. in the first half of 2026, and CFRA has identified five of them as notable launches (see Table 1). We screened the new launches and identified those that have rapidly gathered assets or innovated in growing ETF categories. These products are representative of the rapid and…
Airlines resume some Middle East flights but disruption continues
Airlines resume some Middle East flights but disruption continues
Is It Too Late to Buy Moderna Stock After Its 127% Surge?
Key Points Moderna has made an incredible comeback, surging sixfold over the past year and by around 127% over the past few weeks. The MRNA vaccine company recently announced promising news that could have major implications for its pivot toward oncology. Yet while the pandemic-era darling has made a comeback, shares could pull back as…